Tumor endothelial cells altered glycosylation of ICAM-1, VCAM-1, and PECAM, and lectins, promoting tumor progression and metastasis, and modifying the adhesive properties of endothelial cells (27). This evidence concerns the gene ICAM1 and neoplasm.